Search by Drug Name or NDC
NDC 00135-0624-02 Tums Chewy Bites with Gas Relief 750; 80 mg/1; mg/1 Details
Tums Chewy Bites with Gas Relief 750; 80 mg/1; mg/1
Tums Chewy Bites with Gas Relief is a ORAL TABLET, CHEWABLE in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is CALCIUM CARBONATE; DIMETHICONE.
MedlinePlus Drug Summary
Calcium carbonate is a dietary supplement used when the amount of calcium taken in the diet is not enough. Calcium is needed by the body for healthy bones, muscles, nervous system, and heart. Calcium carbonate also is used as an antacid to relieve heartburn, acid indigestion, and upset stomach. It is available with or without a prescription. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 00135-0624-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Calcium Carbonate
Simethicone is used to treat the symptoms of gas such as uncomfortable or painful pressure, fullness, and bloating. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 00135-0624-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Simethicone
Product Information
| NDC | 00135-0624 |
|---|---|
| Product ID | 0135-0624_41047eed-6d6e-4ffa-bfd6-c82c9e490755 |
| Associated GPIs | 48991002050553 |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Tums Chewy Bites with Gas Relief |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | calcium carbonate and simethicone |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, CHEWABLE |
| Route | ORAL |
| Active Ingredient Strength | 750; 80 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | CALCIUM CARBONATE; DIMETHICONE |
| Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| Pharmaceutical Class | Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Skin Barrier Activity [PE] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part331 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00135-0624-02 (00135062402)
| NDC Package Code | 0135-0624-02 |
|---|---|
| Billing NDC | 00135062402 |
| Package | 54 TABLET, CHEWABLE in 1 BOTTLE (0135-0624-02) |
| Marketing Start Date | 2019-03-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |